The British drugs giant, which is racing to develop a vaccine for Covid-19, has agreed to hand £800m up front to Japan’s Daiichi Sankyo as it is develops a new type of chemotherapy.
Astrazeneca in £4.7bn deal for cancer drug
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]